Literature DB >> 12517891

Comparison of washing and swabbing procedures for collecting genital fluids to assess shedding of human immunodeficiency virus type 1 (HIV-1) RNA in asymptomatic HIV-1-infected women.

Laurent Andréoletti1, Gérard Grésenguet, Nicolas Chomont, Mathieu Matta, Yann Quiniou, Ali Si-Mohamed, Laurent Bélec.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) RNA was detected by means of ultrasensitive reverse transcription-PCR assay of 19 cervicovaginal lavage, 21 cervical mucus, 18 vaginal wall, and 17 vaginal fornix paired samples from 25 asymptomatic HIV-1-infected women (76, 84, 72, and 68%, respectively; P > 0.5). Levels of HIV-1 RNA in cervicovaginal wash samples were highly correlated with those in paired endocervical mucus samples (r = 0.71; P = 0.0006), indicating that cervicovaginal washing and endocervical swabbing are equivalent collection procedures.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12517891      PMCID： PMC149568          DOI： 10.1128/JCM.41.1.449-452.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions.

Authors:  G C John; H Sheppard; D Mbori-Ngacha; R Nduati; D Maron; M Reiner; J Kreiss
Journal:  J Acquir Immune Defic Syndr       Date:  2001-02-01       Impact factor: 3.731

2.  Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding.

Authors:  N Chomont; G Grésenguet; H Hocini; P Becquart; M Matta; L Andreoletti; A Si-Mohamed; M P Carreno; M Kazatchkine; L Bélec
Journal:  AIDS       Date:  2001-04-13       Impact factor: 4.177

3.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

4.  Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).

Authors:  A Si-Mohamed; L Andreoletti; I Colombet; M P Carreno; G Lopez; G Chatelier; M D Kazatchkine; L Belec
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

5.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Authors:  P M Garcia; L A Kalish; J Pitt; H Minkoff; T C Quinn; S K Burchett; J Kornegay; B Jackson; J Moye; C Hanson; C Zorrilla; J F Lew
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

6.  Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention.

Authors:  F X Mbopi-Kéou; G Grésenguet; P Mayaud; H A Weiss; R Gopal; M Matta; J L Paul; D W Brown; R J Hayes; D C Mabey; L Bélec
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

7.  Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy.

Authors:  A Si-Mohamed; M D Kazatchkine; I Heard; C Goujon; T Prazuck; G Aymard; G Cessot; Y H Kuo; M C Bernard; B Diquet; J E Malkin; L Gutmann; L Bélec
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

8.  Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group.

Authors:  P Baron; J Bremer; S S Wasserman; M Nowicki; B Driscoll; B Polsky; A Kovacs; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

9.  Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Authors:  R Chuachoowong; N Shaffer; W Siriwasin; P Chaisilwattana; N L Young; P A Mock; S Chearskul; N Waranawat; T Chaowanachan; J Karon; R J Simonds; T D Mastro
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

10.  Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

Authors:  L Bélec; P D Ghys; H Hocini; J N Nkengasong; J Tranchot-Diallo; M O Diallo; V Ettiègne-Traore; C Maurice; P Becquart; M Matta; A Si-Mohamed; N Chomont; I M Coulibaly; S Z Wiktor; M D Kazatchkine
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226
View more
  7 in total

1.  Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract.

Authors:  Batsirai M Mabvakure; Bronwen E Lambson; Kavisha Ramdayal; Lindi Masson; Dale Kitchin; Mushal Allam; Salim Abdool Karim; Carolyn Williamson; Jo-Ann Passmore; Darren P Martin; Cathrine Scheepers; Penny L Moore; Gordon W Harkins; Lynn Morris
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

2.  Changes in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya.

Authors:  Elijah Odoyo-June; John H Rogers; Walter Jaoko; Robert C Bailey
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-15       Impact factor: 3.731

3.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

4.  Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.

Authors:  Janet M McNicholl; Wanna Leelawiwat; Sara Whitehead; Debra L Hanson; Tammy Evans-Strickfaden; Chen Y Cheng; Wannee Chonwattana; Famui Mueanpai; Chonticha Kittinunvorakoon; Lauri Markowitz; Eileen F Dunne
Journal:  Int J STD AIDS       Date:  2016-07-10       Impact factor: 1.359

5.  Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.

Authors:  Shameem Z Jaumdally; Lindi Masson; Heidi E Jones; Smritee Dabee; Donald R Hoover; Hoyam Gamieldien; Nontokozo Langwenya; Landon Myer; Catherine S Todd; Jo-Ann S Passmore
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

6.  Fractional CO2 laser treatment effect on cervicovaginal lavage zinc and copper levels: a prospective cohort study.

Authors:  Attila G Sipos; Krisztina Pákozdy; Szilvia Jäger; Kindra Larson; Peter Takacs; Bence Kozma
Journal:  BMC Womens Health       Date:  2021-06-06       Impact factor: 2.809

7.  Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid.

Authors:  Kelechi Njoku; Davide Chiasserini; Bethany Geary; Andrew Pierce; Eleanor R Jones; Anthony D Whetton; Emma J Crosbie
Journal:  Cancers (Basel)       Date:  2021-07-28       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.